#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchopulmonary aspergillosis Endocrine ophthalmopathy Pneumonia Hairy cell leukaemia Lupus nephritis Li-Fraumeni syndrome Peripheral primitive neuroectodermal tumour of soft tissue Partial lipodystrophy Hepato-lenticular degeneration Giant cell tumour of tendon sheath Fragile X syndrome Ornithine transcarbamoylase deficiency Adenomatous polyposis coli Medulloblastoma recurrent Guillain-Barre syndrome More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Trials in Disease Wolfram syndrome – Trials in Disease Hepatoblastoma – Life with Disease Mucopolysaccharidosis I – Treatment Familial amyotrophic lateral sclerosis – Treatment Waldenstrom’s macroglobulinaemia – Diagnostics Congenital generalised lipodystrophy – Basic Information Langerhans cell sarcoma – Basic Information Epidermolysis bullosa – Diagnostics Antithrombin III deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Timbetasin Acetate Calcium Levofolinate AZD3632 Ciprofloxacin Rp1 Upacicalcet Sodium Hydrate Pazopanib Imgn151 Mometasone Furoate Monohydrate Cart45Ra-Nkg2D Cells Relacorilant Fosfomycin Omp72 Arginine Hydrochloride Cetrimide Eclitasertib Nizaracianine Triflutate Ceralasertib Fostemsavir Trometamol Bomedemstat More therapies…

    Learn about Your Condition

    Hypoxia Hydrocephalus Multiple sclerosis relapse Malignant melanoma of eyelid Tertiary adrenal insufficiency Premature rupture of membranes Paresis Anal squamous cell carcinoma Leiomyosarcoma Familial mediterranean fever Gout Noonan syndrome Shprintzen-Goldberg syndrome Loeys-Dietz syndrome Ovarian cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Respiratory syncytial virus infection

  • Study on the Safety and Tolerability of Sisunatovir in Infants and Children with RSV Infection

    Not yet recruiting

    1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Sisunatovir
    Poland Spain

  • A study to evaluate the taste of sisunatovir and denatonium benzoate in healthy adults for the treatment of respiratory syncytial virus (RSV)

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Sisunatovir
    Belgium

  • Studying the Effect of Nirsevimab Immunization on Antibody Development After RSV Infection in Healthy Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    The Netherlands

  • Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

    Not recruiting

    3 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • 534
    Finland Germany Spain

  • Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Belgium Poland Spain

  • Study on the Effectiveness of RSV Vaccine (Abrysvo) in Preventing Hospitalizations in Adults Aged 60 and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus infection
    Denmark Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!